CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C28704 | BRD-K82784817 | BRD-K82784817 | -- | -- | -- | Details |
| C28705 | BRD-K82785545 | BRD-K82785545 | -- | -- | -- | Details |
| C28706 | BRD-K82791632 | BRD-K82791632 | -- | -- | -- | Details |
| C28707 | BRD-K82793574 | BRD-K82793574 | -- | -- | -- | Details |
| C28708 | BRD-K82794234 | BRD-K82794234 | -- | -- | -- | Details |
| C28709 | BRD-K82795137 | loratadine | HRH1 | Histamine receptor antagonist | -- | Details |
| C28710 | BRD-K82803470 | BRD-K82803470 | -- | -- | -- | Details |
| C28711 | BRD-K82805160 | BRD-K82805160 | -- | -- | -- | Details |
| C28712 | BRD-K82814298 | BRD-K82814298 | -- | -- | -- | Details |
| C28713 | BRD-K82814367 | BRD-K82814367 | -- | -- | -- | Details |
| C28714 | BRD-K82815491 | BRD-K82815491 | -- | -- | -- | Details |
| C28715 | BRD-K82818427 | batimastat | -- | -- | -- | Details |
| C28716 | BRD-K82822203 | BRD-K82822203 | -- | -- | -- | Details |
| C28717 | BRD-K82823076 | Ro-15-4513 | GABRA1; GABRA2; GABRA3; GABRA5 | GABA benzodiazepine site receptor inverse agonist | -- | Details |
| C28718 | BRD-K82823804 | PD-407824 | -- | -- | SA-792987 | Details |
| C28719 | BRD-K82823857 | BRD-K82823857 | -- | -- | -- | Details |
| C28720 | BRD-K82824976 | BRD-K82824976 | -- | -- | -- | Details |
| C28721 | BRD-K82825326 | BRD-K82825326 | -- | -- | -- | Details |
| C28722 | BRD-K82827604 | BRD-K82827604 | -- | -- | -- | Details |
| C28723 | BRD-K82830100 | BRD-K82830100 | -- | -- | -- | Details |
| C28724 | BRD-K82837433 | BRD-K82837433 | -- | -- | -- | Details |
| C28725 | BRD-K82839033 | BRD-K82839033 | -- | -- | -- | Details |
| C28726 | BRD-K82842087 | BRD-K82842087 | -- | -- | -- | Details |
| C28727 | BRD-K82846253 | repaglinide | KCNJ11; ABCC8 | Insulin secretagogue | -- | Details |
| C28728 | BRD-K82850175 | navarixin | CXCR1; CXCR2 | CCK receptor antagonist | -- | Details |
| C28729 | BRD-K82852523 | BRD-K82852523 | -- | -- | -- | Details |
| C28730 | BRD-K82857306 | I-212148 | -- | -- | -- | Details |
| C28731 | BRD-K82863660 | BRD-K82863660 | -- | -- | -- | Details |
| C28732 | BRD-K82865713 | prostaglandin-b2 | -- | -- | PROSTAGLANDIN-B2 | Details |
| C28733 | BRD-K82868643 | BRD-K82868643 | -- | -- | -- | Details |
| C28734 | BRD-K82869179 | BRD-K82869179 | -- | -- | -- | Details |
| C28735 | BRD-K82869745 | BRD-K82869745 | -- | -- | -- | Details |
| C28736 | BRD-K82870050 | BRD-K82870050 | -- | -- | -- | Details |
| C28737 | BRD-K82877426 | BRD-K82877426 | -- | -- | -- | Details |
| C28738 | BRD-K82881395 | BRD-K82881395 | -- | -- | -- | Details |
| C28739 | BRD-K82882121 | BRD-K82882121 | -- | -- | -- | Details |
| C28740 | BRD-K82882781 | BRD-K82882781 | -- | -- | -- | Details |
| C28741 | BRD-K82883803 | BRD-K82883803 | -- | -- | -- | Details |
| C28742 | BRD-K82886296 | BRD-K82886296 | -- | -- | -- | Details |
| C28743 | BRD-K82899116 | BRD-K82899116 | -- | -- | -- | Details |
| C28744 | BRD-K82899766 | BRD-K82899766 | -- | -- | -- | Details |
| C28745 | BRD-K82903423 | BRD-K82903423 | -- | -- | -- | Details |
| C28746 | BRD-K82906409 | BRD-K82906409 | -- | -- | -- | Details |
| C28747 | BRD-K82909038 | BRD-K82909038 | -- | -- | -- | Details |
| C28748 | BRD-K82909508 | BRD-K82909508 | -- | -- | -- | Details |
| C28749 | BRD-K82910696 | BRD-K82910696 | -- | -- | -- | Details |
| C28750 | BRD-K82911380 | BRD-K82911380 | -- | -- | -- | Details |
| C28751 | BRD-K82919339 | BRD-K82919339 | -- | -- | -- | Details |
| C28752 | BRD-K82922770 | BRD-K82922770 | -- | -- | -- | Details |
| C28753 | BRD-K82924899 | IWP-2 | -- | -- | -- | Details |
| C28754 | BRD-K82925070 | BRD-K82925070 | -- | -- | -- | Details |
| C28755 | BRD-K82927098 | BRD-K82927098 | -- | -- | -- | Details |
| C28756 | BRD-K82927587 | BRD-K82927587 | -- | -- | -- | Details |
| C28757 | BRD-K82928847 | ACY-1215 | HDAC6 | HDAC inhibitor | -- | Details |
| C28758 | BRD-K82930531 | BRD-K82930531 | -- | -- | -- | Details |
| C28759 | BRD-K82933801 | BRD-K82933801 | -- | -- | -- | Details |
| C28760 | BRD-K82935485 | BRD-K82935485 | -- | -- | -- | Details |
| C28761 | BRD-K82935855 | BRD-K82935855 | -- | -- | -- | Details |
| C28762 | BRD-K82941592 | rosuvastatin | HMGCR | HMGCR inhibitor | -- | Details |
| C28763 | BRD-K82957261 | BRD-K82957261 | -- | -- | -- | Details |
| C28764 | BRD-K82963710 | BRD-K82963710 | -- | -- | -- | Details |
| C28765 | BRD-K82967678 | BRD-K82967678 | -- | -- | -- | Details |
| C28766 | BRD-K82967685 | mirodenafil | PDE5A | Phosphodiesterase inhibitor | -- | Details |
| C28767 | BRD-K82968105 | BRD-K82968105 | -- | -- | -- | Details |
| C28768 | BRD-K82968130 | BRD-K82968130 | -- | -- | -- | Details |
| C28769 | BRD-K82971022 | BRD-K82971022 | -- | -- | -- | Details |
| C28770 | BRD-K82971429 | BRD-K82971429 | -- | -- | -- | Details |
| C28771 | BRD-K82983587 | VU-0403126 | -- | -- | -- | Details |
| C28772 | BRD-K82983861 | GW-0742 | PPARD | Insulin sensitizer; PPAR receptor agonist | -- | Details |
| C28773 | BRD-K82986138 | BRD-K82986138 | -- | -- | -- | Details |
| C28774 | BRD-K82987299 | BRD-K82987299 | -- | -- | -- | Details |
| C28775 | BRD-K82989800 | BRD-K82989800 | -- | -- | -- | Details |
| C28776 | BRD-K82991167 | BRD-K82991167 | -- | -- | -- | Details |
| C28777 | BRD-K82993704 | BRD-K82993704 | -- | -- | -- | Details |
| C28778 | BRD-K83001027 | BRD-K83001027 | -- | -- | -- | Details |
| C28779 | BRD-K83003151 | alogliptin | DPP4 | Dipeptidyl peptidase inhibitor | -- | Details |
| C28780 | BRD-K83003953 | BRD-K83003953 | -- | -- | -- | Details |
| C28781 | BRD-K83007718 | BRD-K83007718 | -- | -- | -- | Details |
| C28782 | BRD-K83010055 | VU-0415374-1 | GRM4 | Glutamate receptor modulator | -- | Details |
| C28783 | BRD-K83010768 | BRD-K83010768 | -- | -- | -- | Details |
| C28784 | BRD-K83012560 | BRD-K83012560 | -- | -- | -- | Details |
| C28785 | BRD-K83013052 | BRD-K83013052 | -- | -- | -- | Details |
| C28786 | BRD-K83013900 | BRD-K83013900 | -- | -- | -- | Details |
| C28787 | BRD-K83016905 | BRD-K83016905 | -- | -- | -- | Details |
| C28788 | BRD-K83020231 | DBPR-108 | -- | -- | -- | Details |
| C28789 | BRD-K83023055 | GR-135531 | -- | -- | -- | Details |
| C28790 | BRD-K83025131 | BRD-K83025131 | -- | -- | -- | Details |
| C28791 | BRD-K83028309 | BRD-K83028309 | -- | -- | 5-(4-Bromo-phenyl)-2-phenyl-pyrazolo[1,5-a]pyrimidin-7-ylamine | Details |
| C28792 | BRD-K83030136 | AT-406 | -- | -- | -- | Details |
| C28793 | BRD-K83030741 | BRD-K83030741 | -- | -- | -- | Details |
| C28794 | BRD-K83033340 | BRD-K83033340 | -- | -- | -- | Details |
| C28795 | BRD-K83045795 | BRD-K83045795 | -- | -- | -- | Details |
| C28796 | BRD-K83047454 | BRD-K83047454 | -- | -- | -- | Details |
| C28797 | BRD-K83048312 | JL-7-128 | -- | -- | -- | Details |
| C28798 | BRD-K83049611 | BRD-K83049611 | -- | -- | -- | Details |
| C28799 | BRD-K83057217 | doxifluridine | TYMS | Thymidylate synthase inhibitor | -- | Details |
| C28800 | BRD-K83058591 | BRD-K83058591 | -- | -- | -- | Details |
| C28801 | BRD-K83063356 | RS-102895 | CCR2 | CCR antagonist | -- | Details |
| C28802 | BRD-K83064458 | etofylline | ADORA1 | Adenosine receptor antagonist | -- | Details |
| C28803 | BRD-K83068825 | BRD-K83068825 | -- | -- | -- | Details |